173 related articles for article (PubMed ID: 35119589)
1. Predicting EGFR mutation status by a deep learning approach in patients with non-small cell lung cancer brain metastases.
Haim O; Abramov S; Shofty B; Fanizzi C; DiMeco F; Avisdris N; Ram Z; Artzi M; Grossman R
J Neurooncol; 2022 Mar; 157(1):63-69. PubMed ID: 35119589
[TBL] [Abstract][Full Text] [Related]
2. A deep learning model integrating multisequence MRI to predict EGFR mutation subtype in brain metastases from non-small cell lung cancer.
Li Y; Lv X; Chen C; Yu R; Wang B; Wang D; Hou D
Eur Radiol Exp; 2024 Jan; 8(1):2. PubMed ID: 38169047
[TBL] [Abstract][Full Text] [Related]
3. LDA-SVM-based EGFR mutation model for NSCLC brain metastases: an observational study.
Hu N; Wang G; Wu YH; Chen SF; Liu GD; Chen C; Wang D; He ZS; Yang XQ; He Y; Xiao HL; Huang DD; Xiong KL; Wu Y; Huang M; Yang ZZ
Medicine (Baltimore); 2015 Feb; 94(5):e375. PubMed ID: 25654374
[TBL] [Abstract][Full Text] [Related]
4. Real-world utilization of EGFR TKIs and prognostic factors for survival in EGFR-mutated non-small cell lung cancer patients with brain metastases.
Yu X; Sheng J; Pan G; Fan Y
Int J Cancer; 2021 Sep; 149(5):1121-1128. PubMed ID: 33970485
[TBL] [Abstract][Full Text] [Related]
5. Frequency of brain metastases in non-small-cell lung cancer, and their association with epidermal growth factor receptor mutations.
Iuchi T; Shingyoji M; Itakura M; Yokoi S; Moriya Y; Tamura H; Yoshida Y; Ashinuma H; Kawasaki K; Hasegawa Y; Sakaida T; Iizasa T
Int J Clin Oncol; 2015 Aug; 20(4):674-9. PubMed ID: 25336382
[TBL] [Abstract][Full Text] [Related]
6. Deep Learning Based on Enhanced MRI T1 Imaging to Differentiate Small-cell and Non-small-cell Primary Lung Cancers in Patients with Brain Metastases.
Sui L; Chang S; Xue L; Wang J; Zhang Y; Yang K; Gao BL; Yin X
Curr Med Imaging; 2023; 19(13):1541-1548. PubMed ID: 36717988
[TBL] [Abstract][Full Text] [Related]
7. Contrast-enhanced T1-weighted image radiomics of brain metastases may predict EGFR mutation status in primary lung cancer.
Ahn SJ; Kwon H; Yang JJ; Park M; Cha YJ; Suh SH; Lee JM
Sci Rep; 2020 Jun; 10(1):8905. PubMed ID: 32483122
[TBL] [Abstract][Full Text] [Related]
8. Prognostic analysis of patients with non-small cell lung cancer harboring exon 19 or 21 mutation in the epidermal growth factor gene and brain metastases.
Wang J; Liu Z; Pang Q; Zhang T; Chen X; Er P; Wang Y; Wang P; Wang J
BMC Cancer; 2020 Sep; 20(1):837. PubMed ID: 32883221
[TBL] [Abstract][Full Text] [Related]
9. Epidermal growth factor receptor mutation and pattern of brain metastasis in patients with non-small cell lung cancer.
Baek MY; Ahn HK; Park KR; Park HS; Kang SM; Park I; Kim YS; Hong J; Sym SJ; Park J; Lee JH; Shin DB; Cho EK
Korean J Intern Med; 2018 Jan; 33(1):168-175. PubMed ID: 27093978
[TBL] [Abstract][Full Text] [Related]
10. Epidermal growth factor receptor mutation predicts favorable outcomes in non-small cell lung cancer patients with brain metastases treated with stereotactic radiosurgery.
Yang WC; Xiao F; Shih JY; Ho CC; Chen YF; Tseng HM; Chen KY; Liao WY; Yu CJ; Yang JC; Kuo SH; Cheng JC; Yang PC; Hsu FM
Radiother Oncol; 2018 Feb; 126(2):368-374. PubMed ID: 29111173
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors for brain metastases from non-small cell lung cancer with EGFR mutation: influence of stable extracranial disease and erlotinib therapy.
Sekine A; Satoh H; Iwasawa T; Tamura K; Hayashihara K; Saito T; Kato T; Arai M; Okudela K; Ohashi K; Ogura T
Med Oncol; 2014 Oct; 31(10):228. PubMed ID: 25208818
[TBL] [Abstract][Full Text] [Related]
12. Impact of EGFR mutation and ALK rearrangement on the outcomes of non-small cell lung cancer patients with brain metastasis.
Balasubramanian SK; Sharma M; Venur VA; Schmitt P; Kotecha R; Chao ST; Suh JH; Angelov L; Mohammadi AM; Vogelbaum MA; Barnett GH; Jia X; Pennell NA; Ahluwalia MS
Neuro Oncol; 2020 Feb; 22(2):267-277. PubMed ID: 31648302
[TBL] [Abstract][Full Text] [Related]
13. Development and Validation of a Machine Learning Model to Explore Tyrosine Kinase Inhibitor Response in Patients With Stage IV EGFR Variant-Positive Non-Small Cell Lung Cancer.
Song J; Wang L; Ng NN; Zhao M; Shi J; Wu N; Li W; Liu Z; Yeom KW; Tian J
JAMA Netw Open; 2020 Dec; 3(12):e2030442. PubMed ID: 33331920
[TBL] [Abstract][Full Text] [Related]
14. Driver genes as predictive indicators of brain metastasis in patients with advanced NSCLC: EGFR, ALK, and RET gene mutations.
Wang H; Wang Z; Zhang G; Zhang M; Zhang X; Li H; Zheng X; Ma Z
Cancer Med; 2020 Jan; 9(2):487-495. PubMed ID: 31769228
[TBL] [Abstract][Full Text] [Related]
15. Predicting survival after radiosurgery in patients with lung cancer brain metastases using deep learning of radiomics and EGFR status.
Liao CY; Lee CC; Yang HC; Chen CJ; Chung WY; Wu HM; Guo WY; Liu RS; Lu CF
Phys Eng Sci Med; 2023 Jun; 46(2):585-596. PubMed ID: 36857023
[TBL] [Abstract][Full Text] [Related]
16. High probability and frequency of EGFR mutations in non-small cell lung cancer with brain metastases.
Ge M; Zhuang Y; Zhou X; Huang R; Liang X; Zhan Q
J Neurooncol; 2017 Nov; 135(2):413-418. PubMed ID: 28780743
[TBL] [Abstract][Full Text] [Related]
17. Radiological Features of Brain Metastases from Non-small Cell Lung Cancer Harboring
Takamori S; Toyokawa G; Shimokawa M; Kinoshita F; Kozuma Y; Matsubara T; Haratake N; Akamine T; Mukae N; Hirai F; Tagawa T; Oda Y; Iwaki T; Iihara K; Honda H; Maehara Y
Anticancer Res; 2018 Jun; 38(6):3731-3734. PubMed ID: 29848735
[TBL] [Abstract][Full Text] [Related]
18. EGFR mutations are associated with favorable intracranial response and progression-free survival following brain irradiation in non-small cell lung cancer patients with brain metastases.
Lee HL; Chung TS; Ting LL; Tsai JT; Chen SW; Chiou JF; Leung HW; Liu HE
Radiat Oncol; 2012 Oct; 7():181. PubMed ID: 23110940
[TBL] [Abstract][Full Text] [Related]
19. Identification of predictors for brain metastasis in newly diagnosed non-small cell lung cancer: a single-center cohort study.
Park S; Lee SM; Ahn Y; Kim M; Suh CH; Do KH; Seo JB
Eur Radiol; 2022 Feb; 32(2):990-1001. PubMed ID: 34378076
[TBL] [Abstract][Full Text] [Related]
20. EGFR mutation status and survival after diagnosis of brain metastasis in nonsmall cell lung cancer.
Eichler AF; Kahle KT; Wang DL; Joshi VA; Willers H; Engelman JA; Lynch TJ; Sequist LV
Neuro Oncol; 2010 Nov; 12(11):1193-9. PubMed ID: 20627894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
